Unveiling the power of diet and lifestyle in managing Crohn’s disease
DOI:
https://doi.org/10.12775/JEHS.2023.33.01.007Keywords
Crohn’s disease, inflammatory bowel disease, diet, nutrition, gastroenterology, microbiotaAbstract
Introduction:
Crohn's disease (CD) is an inflammatory bowel disease that can affect any part of the digestive tract. Onset, progression, complications and treatment are influenced by many genetic, environmental and dietary factors. Dietary management is very useful in a variety of gastrointestinal diseases, including CD. Some nutrients have been studied in animal models to exacerbate the disease, while others have strong scientific evidence from large studies in human populations, allowing conclusions to be drawn about their impact on the disease. Dietary management is now a well-established and important part of treatment, in addition to the use of systemic corticosteroids, aminosalicylates, immunomodulators (e.g. azathioprine, 6-mercaptopurine, cyclosporine, tacrolimus) or biologic therapies.
State of knowledge:
To test the associations between the intake of specific macronutrients and the course of CD, we searched the PubMed database focusing on articles about the effects of consumed food components and stimulants on the onset and progression of CD.
Conclusion:
Nutritional treatment plays an important role in the management of CD. An appropriate diet can make a significant contribution to reducing inflammation and attenuating the course and exacerbations of the disease. The intake of proteins, fats, carbohydrates, fiber and certain food additives has been shown in studies to influence the onset and course of CD.
References
Eeckhaut V, Ducatelle R, Sas B, Vermeire S, Van Immerseel F. Progress towards butyrate-producing pharmabiotics: Butyricicoccus pullicaecorum capsule and efficacy in TNBS models in comparison with therapeutics. Gut. 2014 Feb;63(2):367. doi: 10.1136/gutjnl-2013-305293. Epub 2013 Jun 13. PMID: 23766442.
Chicco F, Magrì S, Cingolani A, Paduano D, Pesenti M, Zara F, Tumbarello F, Urru E, Melis A, Casula L, Fantini MC, Usai P. Multidimensional Impact of Mediterranean Diet on IBD Patients. Inflamm Bowel Dis. 2021 Jan 1;27(1):1-9. doi: 10.1093/ibd/izaa097. PMID: 32440680; PMCID: PMC7737160.
Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol. 2010 Oct;105(10):2195-201. doi: 10.1038/ajg.2010.192. Epub 2010 May 11. PMID: 20461067.
Goens D, Micic D. Role of Diet in the Development and Management of Crohn's Disease. Curr Gastroenterol Rep. 2020 Mar 17;22(4):19. doi: 10.1007/s11894-020-0755-9. PMID: 32185530.
Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Willett WC, Richter JM, Chan AT. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut. 2014 May;63(5):776-84. doi: 10.1136/gutjnl-2013-305304. Epub 2013 Jul 4. PMID: 23828881; PMCID: PMC3915038.
Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996 May;63(5):741-5. doi: 10.1093/ajcn/63.5.741. PMID: 8615358.
Pedersen N, Ankersen DV, Felding M, Wachmann H, Végh Z, Molzen L, Burisch J, Andersen JR, Munkholm P. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol. 2017 May 14;23(18):3356-3366. doi: 10.3748/wjg.v23.i18.3356. PMID: 28566897; PMCID: PMC5434443.
Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017 Aug 26;9(9):940. doi: 10.3390/nu9090940. PMID: 28846594; PMCID: PMC5622700.
Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2022 Jun;71(6):1117-1126. doi: 10.1136/gutjnl-2021-325214. Epub 2021 Aug 10. PMID: 34376515.
Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, Ibraim SB, Roume H, Levenez F, Pons N, Maziers N, Lomer MC, Ehrlich SD, Irving PM, Whelan K. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology. 2020 Jan;158(1):176-188.e7. doi: 10.1053/j.gastro.2019.09.024. Epub 2019 Oct 2. PMID: 31586453.
Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients. 2020 Mar 29;12(4):944. doi: 10.3390/nu12040944. PMID: 32235316; PMCID: PMC7230231.
Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, Ibraim SB, Roume H, Levenez F, Pons N, Maziers N, Lomer MC, Ehrlich SD, Irving PM, Whelan K. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology. 2020 Jan;158(1):176-188.e7. doi: 10.1053/j.gastro.2019.09.024. Epub 2019 Oct 2. PMID: 31586453.
Zhou SY, Gillilland M 3rd, Wu X, Leelasinjaroen P, Zhang G, Zhou H, Ye B, Lu Y, Owyang C. FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J Clin Invest. 2018 Jan 2;128(1):267-280. doi: 10.1172/JCI92390. Epub 2017 Nov 27. PMID: 29202473; PMCID: PMC5749529.
Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013 Feb;182(2):375-87. doi: 10.1016/j.ajpath.2012.10.014. Epub 2012 Nov 29. PMID: 23201091; PMCID: PMC3562736.
Zeng L, Hu S, Chen P, Wei W, Tan Y. Macronutrient Intake and Risk of Crohn's Disease: Systematic Review and Dose-Response Meta-Analysis of Epidemiological Studies. Nutrients. 2017 May 15;9(5):500. doi: 10.3390/nu9050500. PMID: 28505133; PMCID: PMC5452230.
Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 2013 Nov;145(5):970-7. doi: 10.1053/j.gastro.2013.07.050. Epub 2013 Aug 2. PMID: 23912083; PMCID: PMC3805714.
Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, Inaba Y, Miyake Y, Sasaki S, Okamoto K, Kobashi G, Washio M, Yokoyama T, Date C, Tanaka H; Epidemiology Group of the Research Committee on Inflammatory Bowel Disease in Japan. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005 Feb;11(2):154-63. doi: 10.1097/00054725-200502000-00009. PMID: 15677909.
Wang H, Shi P, Zuo L, Dong J, Zhao J, Liu Q, Zhu W. Dietary Non-digestible Polysaccharides Ameliorate Intestinal Epithelial Barrier Dysfunction in IL-10 Knockout Mice. J Crohns Colitis. 2016 Sep;10(9):1076-86. doi: 10.1093/ecco-jcc/jjw065. Epub 2016 Mar 3. PMID: 26944415.
Fahoum L, Moscovici A, David S, Shaoul R, Rozen G, Meyron-Holtz EG, Lesmes U. Digestive fate of dietary carrageenan: Evidence of interference with digestive proteolysis and disruption of gut epithelial function. Mol Nutr Food Res. 2017 Mar;61(3). doi: 10.1002/mnfr.201600545. Epub 2017 Jan 25. PMID: 27718308.
Roberts CL, Rushworth SL, Richman E, Rhodes JM. Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of Crohn's disease. J Crohns Colitis. 2013 May;7(4):338-41. doi: 10.1016/j.crohns.2013.01.004. Epub 2013 Jan 27. PMID: 23360575.
Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients. 2020 Mar 29;12(4):944. doi: 10.3390/nu12040944. PMID: 32235316; PMCID: PMC7230231.
Laudisi F, Stolfi C, Monteleone G. Impact of Food Additives on Gut Homeostasis. Nutrients. 2019 Oct 1;11(10):2334. doi: 10.3390/nu11102334. PMID: 31581570; PMCID: PMC6835893.
Ruiz PA, Morón B, Becker HM, Lang S, Atrott K, Spalinger MR, Scharl M, Wojtal KA, Fischbeck-Terhalle A, Frey-Wagner I, Hausmann M, Kraemer T, Rogler G. Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut. 2017 Jul;66(7):1216-1224. doi: 10.1136/gutjnl-2015-310297. Epub 2016 Feb 4. PMID: 26848183; PMCID: PMC5530483.
Tubbs AL, Liu B, Rogers TD, Sartor RB, Miao EA. Dietary Salt Exacerbates Experimental Colitis. J Immunol. 2017 Aug 1;199(3):1051-1059. doi: 10.4049/jimmunol.1700356. Epub 2017 Jun 21. PMID: 28637899; PMCID: PMC5576735.
Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012 Mar;142(3):482-9. doi: 10.1053/j.gastro.2011.11.040. Epub 2011 Dec 9. PMID: 22155183; PMCID: PMC3367959.
Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3. PMID: 29607496; PMCID: PMC6494406.
Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut. 2006 Mar;55(3):356-61. doi: 10.1136/gut.2004.062554. Epub 2005 Sep 14. PMID: 16162683; PMCID: PMC1856067.
Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, Cohen S, Peleg S, Shamaly H, On A, Millman P, Abramas L, Ziv-Baran T, Grant S, Abitbol G, Dunn KA, Bielawski JP, Van Limbergen J. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019 Aug;157(2):440-450.e8. doi: 10.1053/j.gastro.2019.04.021. Epub 2019 Jun 4. PMID: 31170412.
Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis. 2014 Aug;20(8):1353-60. doi: 10.1097/MIB.0000000000000110. PMID: 24983973.
Nie JY, Zhao Q. Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies. Medicine (Baltimore). 2017 Dec;96(49):e9070. doi: 10.1097/MD.0000000000009070. PMID: 29245319; PMCID: PMC5728934.
Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SS, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B, Overvad K, Palli D, Masala G, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Katzke V, Riboli E, Hart AR. No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC). Eur J Clin Nutr. 2017 Apr;71(4):512-518. doi: 10.1038/ejcn.2016.271. Epub 2017 Jan 25. Erratum in: Eur J Clin Nutr. 2017 Apr;71(4):566. PMID: 28120853.
Georgiou AN, Ntritsos G, Papadimitriou N, Dimou N, Evangelou E. Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn's Disease and Ulcerative Colitis: A Mendelian Randomization Study. Inflamm Bowel Dis. 2021 Jan 19;27(2):162-168. doi: 10.1093/ibd/izaa152. PMID: 32628751.
Ott C, Takses A, Obermeier F, Schnoy E, Müller M. Smoking increases the risk of extraintestinal manifestations in Crohn's disease. World J Gastroenterol. 2014 Sep 14;20(34):12269-76. doi: 10.3748/wjg.v20.i34.12269. PMID: 25232261; PMCID: PMC4161812.
Irving PM, Iqbal T, Nwokolo C, Subramanian S, Bloom S, Prasad N, Hart A, Murray C, Lindsay JO, Taylor A, Barron R, Wright S. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis. Inflamm Bowel Dis. 2018 Mar 19;24(4):714-724. doi: 10.1093/ibd/izy002. PMID: 29538683.
Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease. Inflamm Bowel Dis. 2014 Mar;20(3):472-80. doi: 10.1097/01.MIB.0000440982.79036.d6. PMID: 24407485.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Artur Bialic, Kinga Bialic, Rafał Bakalarczyk, Paweł Majewski, Lucjan Bednarz, Karolina Szala-Czerwonka, Natalia Woś, Adrian Rejmer, Katarzyna Rojek, Karolina Wijas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 325
Number of citations: 0